top of page
  • LinkedIn
shutterstock_572848084.jpg

A New Therapeutic Approach to Chronic Wound Healing

Aurase Wound Gel is an investigational biologic that continuously debrides wounds while activating repair pathways to accelerate healing.

SolasCure Webste Wireframe_D2-32.png

Chronic wounds are a global health crisis; millions remain unhealed despite treatment.

SolasCure Webste Wireframe_D2-31.png

Current therapies manage wounds, but rarely restart the biology of repair.

SolasCure Webste Wireframe_D2-33.png

SolasCure is developing Aurase Wound Gel, a Phase II biologic designed to both debride and actively drive healing.

Option 1_TMCi.jpg

Selected for the Innovate UK & TMC Innovation Accelerator Program, in partnership with Texas Medical Center, in 2024

Awarded the Biomedical Catalyst Grant by Innovate UK, the UK's innovation agency in 2024

Awarded EIC Accelerator Grant by the European Innovation Council in 2023

Selected as a 2023 Life Sciences Innovator by UK Department for Business and Trade

1st place in the Biotech Category at EIT Health Catapult (European Institute of Innovation & Technology) in 2022

Winner of the 2019 URGO Mentorship Program

Industry Recognition

pattern.jpg

Aurase Wound Gel has completed its second Phase II clinical trial, demonstrating a substantial acceleration of healing compared with standard care. Full results will be published in the forthcoming clinical study report.

Latest News

17 October 2025 at 10:23:29

THOUGHT LEADERSHIP

17 October 2025

Wound Care Voices: The Unfolding Revolution in Wound Care - Continual Enzymatic Debridement vs Single Intervention

13 October 2025 at 13:38:34

EXTERNAL MEDIA COVERAGE

13 October 2025

SolasCure recognised as one of top three pitches in the 2025 BioCap Pitching Competition

17 September 2025 at 09:44:58

THOUGHT LEADERSHIP

17 September 2025

Wound Care Voices: Why Investors Should Rethink Wound Care

Get in touch with us

By submitting this message I consent to share my name and email address with SolasCure

Aurase Wound Gel combines continuous enzymatic wound bed preparation with activation of endogenous repair pathways, shifting treatment from maintenance toward therapeutic repair.
bottom of page